Dr. Susanna Mak is an associate professor in the Department of Medicine’s Division of Cardiology. She is the Director of the Anna Prosserman Heart Function Clinic and also the Director of the Harold & Esther Mecklinger and the Posluns Family Cardiac Catheterization Research Laboratory at Mount Sinai Hospital. In this facility, Dr. Mak performs her studies of cardiovascular physiology, as well as specialized investigations for advanced heart failure patients. As a clinical cardiologist, she is a heart failure specialist at the Anna Prosserman Heart Function Clinic, which is the longest serving Heart Failure Clinic in Toronto. Dr. Mak received her PhD from the Institute of Medical Sciences at the University of Toronto and is an expert in the assessment of hemodynamics and heart chamber function in humans. Dr. Mak’s research interests include the contrasts between the cardiovascular physiology of men and women, the pathophysiology of pulmonary arterial hypertension and heart failure, and the quality of care for patients with acute and chronic heart failure.
Dr. Mak has recently launched a clinical research program to precisely phenotype the cardiovascular physiologic contributions to dyspnea. Known as the BREATH (Breathlessness Revealed using Exercise to Assess The Hemodynamic response) program, Dr. Mak has received funding from the Heart and Stroke Foundation of Canada, the Canadian Institutes for Health Research and the Ontario Research Fund. The program aims to provide state of the art diagnostics for syndromes of breathlessness related to aging, heart failure with preserved ejection fraction and pulmonary hypertension.
Dr. Stephen Betschel is a clinician-teacher and associate professor in the Department of Medicine’s Division of Clinical Immunology and Allergy, and a staff clinical immunologist and allergist in the Division of Allergy and Clinical Immunology at St. Michael’s Hospital and Division of Respirology at University Health Network. Dr. Betschel also holds courtesy appointments at Michael Garron Hospital and St. Joseph’s Health Centre.
Upon earning his medical degree at McMaster University, Dr. Betschel went on to pursue his residency training in internal medicine, and fellowship in clinical immunology and allergy, at the University of Toronto. Additionally, Dr. Betschel was a Doctor of Philosophy candidate in the Department of Molecular Genetics and Microbiology and identified critical virulence factors associated with Group A Streptococcus ‘flesh eating disease’.
Dr. Betschel’s extensive service to the medical community is demonstrated through various leadership positions locally, nationally and internationally. Dr. Betschel served for 14 years as the training program director in Clinical Immunology and Allergy at the University of Toronto. He currently serves as the chair of the Canadian Hereditary Angioedema Network and has served as a medical advisor to Canadian Blood Services, Hemaquebec, INESSS, CADTH, Immunodeficiency Canada, HAE Canada, and the Canadian Immunodeficiency Society. He has been a member of the National Specialty Committee for over a decade and currently serves as chair of the Royal College of Canada Examination Board in Clinical Immunology and Allergy.
Dr. Betschel’s focus is on rare diseases and occupational allergy. He is the lead author on the Canadian and International Guidelines for Hereditary Angioedema and serves on the steering committee for the World Allergy Organization HAE guidelines. He is director of the Adult Primary Immunodeficiency Clinic at St. Michael’s Hospital where his pharmacoecomonic research was instrumental in recently obtaining a multi-site MOH Funded program for home-based subcutaneous immunoglobulin therapy.
Dr. David Juurlink is an internist and head of the Division of Clinical Pharmacology and Toxicology at Sunnybrook Health Sciences Centre in Toronto. He is also a medical toxicologist at the Ontario Poison Centre at the Hospital for Sick Children and a scientist at the Institute for Clinical Evaluative Sciences.
He received degrees in pharmacy and medicine from Dalhousie University in Halifax, Nova Scotia, and completed postgraduate training in internal medicine followed by residency in clinical pharmacology, a fellowship in medical toxicology, and a PhD in clinical epidemiology, all at the University of Toronto. He received certification by the American Board of Internal Medicine, the American Board of Clinical Pharmacology, and the American Board of Emergency Medicine (Medical Toxicology.)
He is presently the principal consultant and Sunnybrook site director for the program in clinical pharmacology and vice-chair of the Examination Board of the Royal College of Physicians and Surgeons program in clinical pharmacology and toxicology. In addition to his clinical, teaching and administrative activities, he maintains an active research program in the field of drug safety. His areas of particular interest include adverse drug events, the clinical consequences of drug-drug interactions in real-world practice, and the epidemiology of suicide and para-suicide.
Dr. Laurent Brochard is the Interdepartmental Division Director, Critical Care, at the University of Toronto. He is a full professor and clinician-scientist in the Division of Critical Care at St. Michael’s Hospital. He was previously working in Geneva as head of the Intensive Care Unit of the Geneva University Hospital, in Switzerland for three years. Most of his career took place at Henri Mondor Hospital, Assistance Publique – Hôpitaux de Paris, and at Paris EST University, France. He has a strong involvement in research, and especially clinical research about mechanical ventilation. He has been editor-in-chief of the journal, Intensive Care Medicine, from 2001 to 2007 and is currently serving as deputy editor for the American Journal of Respiratory and Critical Care Medicine. He is leading a European Research Network dedicated to clinical studies in mechanical ventilation called REVA.
Dr. Vincent Piguet trained at the School of Medicine, University of Geneva, graduating in 1995. He spent two years doing research in virology and immunology at the Salk Institute in San Diego, USA before obtaining his MD and PhD in 2000/2001 and specialist certification in dermatology and venereology in 2004 from the Swiss Medical Association. He received a prestigious fellowship from the Swiss National Science Foundation in 2003 and was subsequently promoted to assistant and then associate professor at the University of Geneva.
In 2010, Dr. Piguet joined Cardiff University in the UK as Professor and Chair of the Department of Dermatology and Wound Healing. He was also appointed consultant dermatologist at the University Hospital of Wales. In 2011, he obtained UK certification in dermatology and in 2014 became a fellow of the Royal College of Physicians. In 2011, he was appointed director of the School of Medicine Institute of Infection and Immunity and in 2015, director of the School of Medicine Division of Infection and Immunity. In 2017, he was appointed as full professor and Department Division Director, Dermatology, in the Department of Medicine at the University of Toronto and Division Head, Division of Dermatology, Women’s College Hospital.
Dr. Piguet has authored more than 145 publications in the fields of dermatology, dendritic cells, HIV, immunology and vaccination in a range of highly cited peer review journals such as Cell, Immunity, The Lancet, Proceedings of the National Academy of Sciences, Journal of Investigative Dermatology, Blood, and Nature Medicine. He has received numerous grants (including as principal investigator from the Human Frontier Science Program and the Bill & Melinda Gates Foundation) to further his research including in the areas of HIV and mucosal transmission, psoriasis and melanoma.
Dr. Piguet’s laboratory will be housed in the Medical Sciences Building and his clinical and administrative offices will be based at Women’s College Hospital.
Dr. Anil Chopra completed his fellowship in emergency medicine at the University of Toronto and has been active staff at the University Health Network (UHN) since 1994. He has been the chief of the Emergency Department at the UHN for the last ten years and is associate professor in the Department of Medicine at the University of Toronto. Dr. Chopra has also been an active member of the Department of Medicine’s Continuing Faculty Appointment Review Committee.
Dr. Chopra is a very well regarded administrator and clinician who has a passion for quality improvement and innovation. He has received several teaching awards including the W.A. Anderson Teaching Award for Undergraduate Teaching and the Anna Jarvis Award for Postgraduate Teaching Excellence. His clinical and research interests are in the area of arterial and venous thromboembolism and he is an executive member of Thrombosis Canada. Dr. Chopra has numerous publications focused on the assessment, prevention and management of thromboembolism.
Dr. Jacqueline James completed her MD in internal medicine, subspecialty training in endocrinology and metabolism, and Master’s of Education at the University of Toronto. She is a clinician-educator and professor in the Department of Medicine and has been a proud member of the community of clinical teachers and educators at the University of Toronto since joining the Division of Endocrinology and Metabolism in 1995.
Dr. James has made excellent and sustained contributions to the Faculty of Medicine through a variety of educational leadership roles throughout her career and she has provided outstanding academic service in support of the MD program, postgraduate, continuing professional development and interprofessional education. She was the recipient of University of Toronto Colin R. Woolf Award for Excellence in Course Coordination in 2005, for her work with the Banting and Best Diabetes Centre, the Department of Medicine Teacher of the Year Award in 2014 in recognition of her contributions to the Department’s educational mission, and the Faculty of Medicine W. T. Aikins Award for Course or Program Development and Coordination in 2017 in recognition of outstanding contributions to the MD Program.
Dr. James was director of the Faculty of Medicine Wightman-Berris Academy from 2006 to 2017, and has been Vice-President, Education, Sinai Health System since 2011. As past chair of the Banting and Best Diabetes Centre, Care and Education Committee, she led the development and funding of educational and research programs for health professionals throughout the Toronto region. She is passionate about bringing individuals across all health professional disciplines, clinical and academic sites with a common goal of improving healthcare delivery through providing outstanding educational and research experiences for the next generation of clinicians and investigators.
Her goal as division director will be to continue to nurture and support the already highly successful diabetes and metabolic research programs across the university, while building on existing strengths in endocrinology and endocrine oncology to grow research endeavours in these areas. She will also aim to strengthen the quality of person-centred care through innovation and collaboration across all affiliated university sites.
Her general endocrinology practice is based at Mount Sinai Hospital and she has a special interest in caring for people with Type 1 diabetes transitioning to adult care.
Dr. Laura Targownik graduated from the University of Manitoba Medical School in 1997 and completed her residency training in Internal Medicine in 2000. She then went to University of California Los Angeles (UCLA) to complete a 3-year fellowship in Digestive Diseases while also obtaining a Master’s of Science (Health Services) from the UCLA School of Public Health.
Since 2003, Dr. Targownik has been a full-time faculty member at the University of Manitoba in the Section of Gastroenterology where she currently holds the rank of Associate Professor. She is also an Associate of the Manitoba Centre for Health Policy and is the Associate Director of the IBD Research and Clinical Centre. Prior to joining the Department of Medicine as Division Director for Gastroenterology & Hepatology, she was the Chief of the Section of Gastroenterology at University of Manitoba.
Dr. Targownik is a nationally recognized researcher in IBD and has held funding from Crohn’s and Colitis Canada, the American College of Gastroenterology and the Canadian Institutes of Health Research. She is currently an Associate Editor for the American Journal of Gastroenterology and has served on the Examiner’s Board on the Royal College of Physicians and Surgeons of Canada for Gastroenterology.
Dr. Targownik is a member of numerous research consortia, including the Canadian IBD Research Consortium, the Canadian Gastrointestinal Epidemiology Consortium and the Canadian IBD Transitions in Care Network. She is also the chair for Equity and Diversity for the Canadian Association of Gastroenterology where she is spearheading several initiatives with the aim of improving the representation of women in positions of leadership and influence in gastroenterology. She has authored or co-authored over 120 articles in peer-reviewed publications. Her current focus of research is in using secondarily collected data sources to evaluate the costs and benefits of medications used in IBD.
Dr. Moira Kapral is a professor in the Department of Medicine and holds the Mr. Mak Pak Chiu and Mrs. Mak-Soo Lai Hing Chair in General Internal Medicine. She is a staff physician in the Division of General Internal Medicine at the University Health Network (UHN)/Mount Sinai Hospital where she also holds the Lillian Love Chair in Women’s Health. Her research focus is on stroke health services research and she is a senior scientist at ICES and the Toronto General Research Institute. She has held national career awards from the Canadian Institutes for Health Research (2006-2011) and the Heart and Stroke Foundation of Canada (2011-2016; 2017-2021). Dr. Kapral is the co-principal investigator of the Ontario Stroke Registry.
She served as internal medicine clerkship coordinator (1998-2004) and site director for the Internal Medicine Postgraduate Program (2005-2008) at the Toronto General Hospital. She has received prestigious University of Toronto awards including the Mary Hollington Award for Teaching, the Aikens Award for Teaching and the Wightman-Berris Academy Award for Teaching. She also received numerous UHN awards including the Scott-Vellend Award for Sustained Excellence Teaching and the J.G. Scott Teacher of the Year Award.
Dr. Barbara Liu is a Professor of Medicine at the University of Toronto. She is also the Executive Director of the Regional Geriatric Program of Toronto (RGP) and leads a network of 23 hospitals in the delivery of specialized geriatric services. In Ontario she has been leading the implementation of senior friendly hospital/senior friendly care framework in collaboration with decision makers, hospitals and front-line providers. Through her clinical work and administrative leadership, she is deeply committed to the care of older people and the vision of “Better health outcome for frail seniors”.
Dr. Isaac Odame
Dr. Isaac Odame is a staff physician in the Division of Hematology/Oncology and the Centre for Global Child Health at the Hospital for Sick Children, Toronto, Canada. He is a full professor and director of the combined Division of Adult and Pediatric Hematology in the Departments of Medicine and Pediatrics, Faculty of Medicine, University of Toronto. He holds the Alexandra Yeo Chair in Hematology at the University of Toronto.
The focus of Dr. Odame’s academic work and clinical care are patients with sickle cell disease, and thalassemias and other hematological disorders. Currently, Dr. Odame is the director of the Global Sickle Cell Disease Network based at the Hospital for Sick Children and Centre for Global Child Health that is committed to building enduring collaborations between clinicians and scientists worldwide. Under his leadership sickle cell disease clinicians and scientists across Africa, the Middle East, India, Europe and North and South America are working more collaboratively in research initiatives aimed at delivering interventions that are evidence-based, cost-effective and sustainable over the long-term, particularly in low-income countries with the highest disease burden.
Dr. Odame was previously an associate professor at McMaster University where he was also the director of the residency program in Pediatric Hematology/Oncology. He is a medical graduate of the University of Ghana and undertook his specialty training in pediatrics and hematology/hematopathology in the UK.
Dr. Rupert Kaul is a full professor and Division Director, Division of Infectious Diseases, University of Toronto, and division head, Infectious Diseases, at the University Health Network/Mount Sinai Hospital. Dr. Kaul became interested in HIV research soon after completing his infectious disease clinical training. For his initial research exposure, Dr. Kaul travelled to Nairobi where he studied a population of HIV resistant sex workers in Nairobi under the supervision of Dr. Frank Plummer from Winnipeg, and the linkage between sexually transmitted disease prevention and HIV in a separate cohort with Dr. Stephen Moses. Today, Dr. Kaul's research investigates the immune correlates of HIV susceptibility and transmission in cohorts of people from Canada, Uganda and Kenya.
Dr. Krzyzanowska is a medical oncologist and health services researcher at the Princess Margaret Cancer Centre and a Professor of Medicine at U of T. Her research focuses on the interplay between the science and practice of healthcare quality as it relates to the delivery of cancer care. By combining patient-level studies with population-based research, she is able to look at quality issues from different but complementary perspectives, which have impact at both the micro (institution) as well as macro (population) level and close the loop between quality measurement and improvement.
Dr. Krzyzanowska has held a number of leadership roles related to quality at Cancer Care Ontario, Princess Margaret Cancer Centre, University of Toronto and with the American Society of Clinical Oncology. She is an Associate Editor at the Journal of Oncology Practice and the Chair of the 2018 ASCO Quality Care Symposium. Dr. Krzyzanowska obtained her medical degree and clinical training at the University of Toronto then completed a research fellowship at the Centre for Outcomes and Policy Research at the Dana Farber Cancer Institute.
At the 2018 Annual Day, Dr. Krzyzanowska was promoted to Professor and received the Department of Medicine Award in Quality and Innovation.
Dr. Rulan Parekh is Associate Chief, Clinical Research and Senior Scientist at the Hospital for Sick Children and University Health Network, and Professor of Paediatrics and Medicine in the Departments of Paediatrics, Medicine, Epidemiology, and Health Policy and Management Evaluation at the University of Toronto.
Dr. Parekh is a clinician scientist, nephrologist and an international leader in clinical epidemiology and translational research in kidney disease. Her body of work has revealed novel genetic risk factors leading to kidney disease, and increased risk of morbidity and mortality for children and adults with kidney disease.
At the University of Michigan, Dr. Parekh was uniquely trained in pediatrics and internal medicine with subspecialty training in both pediatric and adult nephrology as well as research training, completing her Master’s in Biostatistics and Study Design. She subsequently went on to post-doctoral training at Johns Hopkins University and joined the faculty in 2000. She successfully competed for a National Institutes of Health (NIH) Career Development Research Award, and the American Society of Nephrology Carl W. Gottschalk Award for young investigators, establishing research programs in the genetics and cardiovascular complications of kidney disease.
In 2008, she returned to Canada and accepted a faculty position at the University of Toronto and a scientist position with the SickKids Research Institute. Since 2000, Dr. Parekh has maintained a record of sustained NIH and CIHR funding. She has significant productivity with more than 160 published manuscripts, over 4,000 citations and a stellar track record of training and mentoring 80 students and post-doctoral trainees. She has received several awards including the National Kidney Foundation of Maryland Award, Advising, Mentoring and Teaching Research Award, and was elected into academic honour societies such as the American Society of Clinical Investigation, the Pediatric Academic Society and the American Pediatric Society. More recently, Dr. Parekh was named Canada Research Chair in Chronic Kidney Disease by CIHR.
Dr. David Tang-Wai is an associate professor in neurology and geriatric medicine at the University of Toronto. He received his MD degree from McGill University. He completed his neurology residency and behavioral neurology fellowship at the Mayo Clinic.
Dr. Tang-Wai is the co-director of University Health Network Memory Clinic, former program director of the adult neurology residency program at UofT, and currently the strategic director for the Division of Neurology. He is also an active member of the Toronto Dementia Research Alliance. He has received multiple teaching awards and nominations from undergraduate and postgraduate trainees. Dr. Tang-Wai's research interests include the progressive aphasias, the atypical presentations of Alzheimer's disease – especially posterior cortical atrophy, normal pressure hydrocephalus, and the autoimmune encephaltis.
Dr. Anil Adisesh studied medicine at the University of Liverpool, UK and then specialized in occupational medicine at Guy’s and St Thomas’ hospitals, King’s College London (UK). He went on to complete his specialist training and doctoral studies on exhaled breath nitric oxide and the respiratory health effects of occupational organic dust exposures at the University of Manchester.
In 1997, Anil became Specialty Director for Occupational Health at the University Hospital of Wales, Cardiff, UK, later moving back to Manchester and subsequently to the UK Health and Safety Laboratory where he was Deputy Chief Medical Officer until 2013. He was then the inaugural JD Irving Research Chair in Occupational Medicine at Dalhousie University in Halifax, Nova Scotia before moving to Toronto. Anil has Chaired the WHO ICD-11 revision for Occupational Health, and Co-chaired work to produce exposure and diagnostic criteria for occupational diseases for the International Labour Organisation.
The overarching theme to Anil’s research is “promoting long and healthy working lives.” This theme recognizes the benefit of work to individuals, the necessity of longer working lives in a world with an aging population, and the prevention of work-related disease. Dr. Adisesh has a research interest in the role of the exposome in disease causation. His current research includes using toenails as a biomatrix for metallome profiling comparing cancer cases with controls, and investigating the effects of work and health with the Atlantic PATH Cohort. In clinical service provision, he plans to establish the potential for digital technologies to be incorporated in clinical occupational medicine practice.
Dr. Ebru Kaya graduated from her residency training in palliative medicine in the UK and immigrated to Canada in 2006. She is a mother, a wife, a doctor and an educator whose passion is in non-cancer palliative care. Dr. Kaya is an Associate Professor in the Department of Medicine and is the Program Director for the Royal College residency training program in palliative medicine at the University of Toronto. She is also the co-director for the Clinical Fellowship program for the Division and the Palliative Care Site Lead for the Toronto General Hospital. Dr. Kaya was co-recipient of a Temerty Faculty of Medicine Award for Excellence in Postgraduate Medical Education this year. She has made important contributions to palliative care at the national level in the Canadian Society for Palliative Care Physicians, where she has served as Treasurer and currently is President-Elect.
She currently divides her time between provision of clinical services, teaching, and in her leadership roles for UHN, the Division of Palliative Medicine and the Canadian Society of Palliative Care Physicians.
Originally from Boston, Dr. Larry Robinson completed his physical medicine and rehabilitation (PM&R) residency at Northwestern University/Rehabilitation Institute of Chicago. He was at the University of Washington (UW) in Seattle for over 25 years where he took on a variety of administrative roles: service chief at Harborview (a Seattle hospital not unlike Sunnybrook Health Sciences Centre); UW department chair; and US vice dean for PGME and Clinical Affairs. He moved to the University of Toronto in 2014.
Dr. Robinson has been involved in a number of national activities in PM&R in the US and Canada. He was a director for the American Board of PM&R. He has also served as chair of the American Board of Electrodiagnostic Medicine (ABEM) and has received a lifetime achievement award from the American Association of Neuromuscular and Electrodiagnostic Medicine (AANEM). Dr. Robinson serves as an associate editor for the American Journal of PM&R. He is president of the Canadian Association of PM&R (CAPMR).
Dr. Robinson has more than 175 journal articles in the peer reviewed medical literature. These are primarily related to electrodiagnosis and electrophysiology. They cover diagnosis and prognosis of focal neuropathies, continuum of care for trauma patients, and impact of board certification.
Dr. Douglas Bradley is Professor of Medicine and Department Division Director, Respirology, at the University of Toronto, the Cardiopulmonary Sleep Disorders and Research Centre at the Toronto General Hospital/University Health Network, and the Sleep Research Laboratory at the Toronto Rehabilitation Institute. He also holds the Cliff Nordal Chair in Sleep Apnea and Rehabilitation Research at the Toronto Rehabilitation Institute and the Godfrey S. Pettit Chair in Respiratory Medicine.
Dr. Bradley completed his MD degree at the University of Alberta in Edmonton in 1978. Subsequently, he completed specialty training at the University of Toronto in internal medicine in 1982 and respirology in 1985. Following completion of clinical training he went on to complete three years of research training in sleep apnea and respiratory muscle physiology at the University of Toronto and McGill University, respectively. He has been on staff at the Toronto General Hospital and at the University of Toronto since 1985.
His clinical and research work focuses on the relationship between sleep apnea and cardiovascular diseases, with a particular focus on the pathophysiology and treatment of sleep apnea in patients with heart failure. He holds several peer reviewed grants from the Canadian Institutes of Health Research (CIHR), the Ontario Centres of Excellence and the Heart and Stroke Foundation of Ontario. He has published over 200 papers and book chapters on sleep apnea and related topics.
Dr. Heather McDonald-Blumer completed her internal medicine and rheumatology training at the University of Toronto. Following initial community rheumatology practice, she transitioned to a full-time academic appointment in the Department of Medicine in 2004.
Dr. McDonald-Blumer is a member of the Division of Rheumatology at Mount Sinai Hospital/University Health Network. Her clinical interests include osteoporosis and inflammatory joint disease. She is the associate director of the Osteoporosis Program at University Health Network and is a member of the Scientific Advisory Committee and Chair of the Guidelines Committee for Osteoporosis Canada.
She has been an active member of the rheumatology community locally and nationally, having served as the University of Toronto Program Director for Rheumatology as well as Chair of the Specialty Committee in Rheumatology and Chair of the Examination Board for Rheumatology for the Royal College of Physicians and Surgeons of Canada. Her work has advanced rheumatology training across the country through curricular innovations. In recognition of these contributions, Dr. McDonald-Blumer was awarded the Royal College Program Director of the Year Award as well as the inaugural Canadian Rheumatology Association Teacher/Educator of the Year Award.
From 2009-2016, Dr. McDonald-Blumer was the Program Director for the Internal Medicine Residency Training Program in the Department of Medicine. She was awarded the William Goldie Award for medical education and the Teacher of the Year Award to recognize the impact of her work and leadership within the internal medicine program. Complementing her local role, she was the Vice-Chair of the Canadian Association of Internal Medicine Program Directors during 2015-2016, a group working to share best educational practices in internal medicine training within the Royal College competency based medical education framework.
Since 2016, Dr McDonald-Blumer has returned to her rheumatology roots and is currently the Division Director for Rheumatology at the University of Toronto. In additional to her clinical work and educational role as Director for Competence-by-Design for the Department of Medicine, her greatest professional rewards come from facilitating, supporting and celebrating the work of the members of the division as they advance clinical care, provide unparalleled rheumatology educational experiences and further research activities to benefit patients with rheumatic disease.